202 related articles for article (PubMed ID: 17978171)
41. Structure-based virtual screening of small-molecule antagonists of platelet integrin αIIbβ3 that do not prime the receptor to bind ligand.
Negri A; Li J; Naini S; Coller BS; Filizola M
J Comput Aided Mol Des; 2012 Sep; 26(9):1005-15. PubMed ID: 22893377
[TBL] [Abstract][Full Text] [Related]
42. Hypoxia impairs agonist-induced integrin α
Kiouptsi K; Gambaryan S; Walter E; Walter U; Jurk K; Reinhardt C
Sci Rep; 2017 Aug; 7(1):7621. PubMed ID: 28790378
[TBL] [Abstract][Full Text] [Related]
43. A novel family of RGD-containing disintegrins (Tablysin-15) from the salivary gland of the horsefly Tabanus yao targets αIIbβ3 or αVβ3 and inhibits platelet aggregation and angiogenesis.
Ma D; Xu X; An S; Liu H; Yang X; Andersen JF; Wang Y; Tokumasu F; Ribeiro JM; Francischetti IM; Lai R
Thromb Haemost; 2011 Jun; 105(6):1032-45. PubMed ID: 21475772
[TBL] [Abstract][Full Text] [Related]
44. Variation in the ability of glycoprotein IIb-IIIa antagonists to exert and maintain their inhibitory effects on the binding of fibrinogen.
Schneider DJ; Baumann PQ; Whitaker DA; Sobel BE
J Cardiovasc Pharmacol; 2005 Jul; 46(1):41-5. PubMed ID: 15965353
[TBL] [Abstract][Full Text] [Related]
45. Significance of RGD loop and C-terminal domain of echistatin for recognition of alphaIIb beta3 and alpha(v) beta3 integrins and expression of ligand-induced binding site.
Marcinkiewicz C; Vijay-Kumar S; McLane MA; Niewiarowski S
Blood; 1997 Aug; 90(4):1565-75. PubMed ID: 9269775
[TBL] [Abstract][Full Text] [Related]
46. Glycoprotein IIb/IIIa inhibitors increase COAT-platelet production in vitro.
Hamilton SF; Miller MW; Thompson CA; Dale GL
J Lab Clin Med; 2004 May; 143(5):320-6. PubMed ID: 15122176
[TBL] [Abstract][Full Text] [Related]
47. The Platelet Integrin αIIbβ3 Differentially Interacts with Fibrin Versus Fibrinogen.
Litvinov RI; Farrell DH; Weisel JW; Bennett JS
J Biol Chem; 2016 Apr; 291(15):7858-67. PubMed ID: 26867579
[TBL] [Abstract][Full Text] [Related]
48. A new Ser472Asn (Cab2(a+)) polymorphism localized within the αIIb "thigh" domain is involved in neonatal thrombocytopenia.
Jallu V; Dusseaux M; Kaplan C
Transfusion; 2011 Feb; 51(2):393-400. PubMed ID: 20723174
[TBL] [Abstract][Full Text] [Related]
49. Von Willebrand factor can support platelet aggregation via interaction with activated GPIIb-IIIa and GPIb.
Naimushin YA; Mazurov AV
Platelets; 2004 Nov; 15(7):419-25. PubMed ID: 15745313
[TBL] [Abstract][Full Text] [Related]
50. Reassessment of protein tyrosine phosphorylation in thrombasthenic platelets: evidence that phosphorylation of cortactin and a 64-kD protein is dependent on thrombin activation and integrin alphaIIb beta3.
Rosa JP; Artçanuthurry V; Grelac F; Maclouf J; Caen JP; Lévy-Toledano S
Blood; 1997 Jun; 89(12):4385-92. PubMed ID: 9192762
[TBL] [Abstract][Full Text] [Related]
51. Divalent cations differentially regulate integrin alphaIIb cytoplasmic tail binding to beta3 and to calcium- and integrin-binding protein.
Vallar L; Melchior C; Plançon S; Drobecq H; Lippens G; Regnault V; Kieffer N
J Biol Chem; 1999 Jun; 274(24):17257-66. PubMed ID: 10358085
[TBL] [Abstract][Full Text] [Related]
52. The beta3 subunit of the integrin alphaIIbbeta3 regulates alphaIIb-mediated outside-in signaling.
Liu J; Jackson CW; Gruppo RA; Jennings LK; Gartner TK
Blood; 2005 Jun; 105(11):4345-52. PubMed ID: 15701721
[TBL] [Abstract][Full Text] [Related]
53. αIIbβ3 binding to a fibrinogen fragment lacking the γ-chain dodecapeptide is activation dependent and EDTA inducible.
Zafar H; Shang Y; Li J; David GA; Fernandez JP; Molina H; Filizola M; Coller BS
Blood Adv; 2017 Feb; 1(7):417-428. PubMed ID: 29296957
[TBL] [Abstract][Full Text] [Related]
54. Association between ligand-induced conformational changes of integrin IIbbeta3 and IIbbeta3-mediated intracellular Ca2+ signaling.
Honda S; Tomiyama Y; Aoki T; Shiraga M; Kurata Y; Seki J; Matsuzawa Y
Blood; 1998 Nov; 92(10):3675-83. PubMed ID: 9808561
[TBL] [Abstract][Full Text] [Related]
55. Allicin and disulfiram enhance platelet integrin alphaIIbbeta3-fibrinogen binding.
Manaster Y; Shenkman B; Rosenberg N; Savion N
Thromb Res; 2009 Sep; 124(4):477-82. PubMed ID: 19632706
[TBL] [Abstract][Full Text] [Related]
56. Structure-activity relationships of alphaIIb 313-320 derived peptide inhibitors of human platelet aggregation.
Stanica RM; Benaki D; Rodis FI; Mikros E; Tsoukatos D; Tselepis A; Tsikaris V
J Pept Sci; 2008 Nov; 14(11):1195-202. PubMed ID: 18646252
[TBL] [Abstract][Full Text] [Related]
57. A mechanistic model for paradoxical platelet activation by ligand-mimetic alphaIIb beta3 (GPIIb/IIIa) antagonists.
Bassler N; Loeffler C; Mangin P; Yuan Y; Schwarz M; Hagemeyer CE; Eisenhardt SU; Ahrens I; Bode C; Jackson SP; Peter K
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):e9-15. PubMed ID: 17170374
[TBL] [Abstract][Full Text] [Related]
58. The ligand recognition specificity of beta3 integrins.
Suehiro K; Smith JW; Plow EF
J Biol Chem; 1996 Apr; 271(17):10365-71. PubMed ID: 8626608
[TBL] [Abstract][Full Text] [Related]
59. Integrins involved in the adhesion of megakaryocytes to fibronectin and fibrinogen.
Schick PK; Wojenski CM; He X; Walker J; Marcinkiewicz C; Niewiarowski S
Blood; 1998 Oct; 92(8):2650-6. PubMed ID: 9763546
[TBL] [Abstract][Full Text] [Related]
60. Critical residues of integrin alphaIIb subunit for binding of alphaIIbbeta3 (glycoprotein IIb-IIIa) to fibrinogen and ligand-mimetic antibodies (PAC-1, OP-G2, and LJ-CP3).
Kamata T; Irie A; Tokuhira M; Takada Y
J Biol Chem; 1996 Aug; 271(31):18610-5. PubMed ID: 8702512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
